Albert David Ltd.

BSE: ALBERTDAVD524075ISIN INE155C01010

Healthcare
Pharmaceuticals

Share price

₹761.00-10.00 (-1.30%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹925.00
52W low: ₹581.30
Off 52W high: -17.73%
1M return: -8.90%
3M return: +9.81%
6M return: -5.61%
1Y return: -12.82%
20D avg volume: 105
50 DMA: ₹830.74
200 DMA: ₹742.13

Key ratios Standalone

Market cap: ₹434.32 Cr
Current price: ₹761.00
52W high / low: ₹925.00 / ₹581.30
Face value: ₹10.00
P/E: 19.25
P/B: 1.05
EPS (TTM): ₹39.54
Book value / share: ₹724.76
ROE: 5.46%
ROCE: 0.80%
Operating margin: 38.09%
Net margin: 31.58%
Debt / equity: 0.07
Net debt: ₹28.18 Cr
Interest cover: 1.20
Dividend yield: 0.66%
Dividend / share (TTM): ₹5.00
Payout: 12.65%
Cash conversion cycle: 65.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	101.34	85.86	89.93	87.24	70.57	74.89	83.08	98.44	89.36	89.06	88.28	93.18
	27.96	-24.84	12.40	-2.14	22.04	5.11	9.01	20.64	23.06	10.44	16.88	12.10
	129.30	61.02	102.33	85.10	92.60	69.78	74.08	119.08	112.42	99.50	105.16	105.27
	93.50	86.26	82.42	87.68	84.16	81.59	84.24	93.94	90.36	81.39	81.73	78.73
	18.33	17.91	16.75	11.99	13.25	20.90	17.43	16.33	15.50	17.35	15.81	14.78
	12.39	14.06	14.58	10.45	9.91	18.55	16.32	12.67	12.92	19.53	15.44	13.87
	25.55	23.08	23.90	27.07	28.43	22.68	28.61	29.31	28.37	22.72	23.09	20.43
	0.52	0.43	0.90	0.75	0.55	0.13	0.13	0.06	0.09	0.07	0.12	0.06
	2.29	2.72	2.42	2.23	2.39	1.82	1.70	1.67	1.78	1.83	1.68	1.46
	28.96	29.93	27.37	26.97	27.51	27.63	27.47	32.58	29.81	27.12	24.04	25.14
	35.79	-25.23	19.90	-2.58	8.44	-11.81	-10.16	25.14	22.06	18.11	23.44	26.55
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	35.79	-25.23	19.90	-2.58	8.44	-11.81	-10.16	25.14	22.06	18.11	23.44	26.55
	3.80	-3.80	4.60	0.72	0.50	1.48	0.77	7.06	3.22	5.20	4.72	6.25
	32.00	-21.43	15.30	-3.30	7.94	-10.33	-9.39	18.07	18.84	12.91	18.72	20.30
	56.07	-37.56	26.81	-5.79	13.91	-18.10	-16.45	31.67	33.02	22.63	32.80	35.57
Key metrics
	38.60	-22.08	23.22	0.40	11.38	-9.86	-8.33	26.87	23.93	20.01	25.24	28.07
	38.10%	-25.70%	25.80%	0.50%	16.10%	-13.20%	-10.00%	27.30%	26.80%	22.50%	28.60%	30.10%
	31.60%	-25.00%	17.00%	-3.80%	11.30%	-13.80%	-11.30%	18.40%	21.10%	14.50%	21.20%	21.80%
	—	-6.10%	—	-0.40%	—	-2.90%	—	—	—	—	—	—
	43.60%	14.60%	8.20%	-11.40%	-21.00%	-15.90%	-5.90%	5.60%	—	—	—	—
	303.00%	-107.50%	262.90%	-118.30%	-57.90%	-180.00%	-150.20%	-11.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	364.37	333.60	345.77	362.46	341.56	313.51
	13.38	7.45	29.58	57.55	15.40	15.84
	377.75	341.05	375.35	420.01	356.96	329.35
	349.86	340.53	350.12	322.73	306.23	282.06
	64.98	59.89	70.15	63.92	63.54	51.46
	51.48	49.01	60.46	64.25	64.15	61.10
	99.60	102.48	109.02	88.43	81.07	85.38
	2.60	2.63	0.41	0.32	0.46	0.53
	9.66	9.76	6.97	6.83	8.55	8.81
	113.23	111.79	117.43	100.75	93.06	72.40
	27.88	0.53	25.23	97.28	50.73	47.30
	0.00	0.00	0.00	—	—	—
	27.88	0.53	25.23	97.28	50.73	47.30
	5.32	2.02	8.03	21.86	14.56	12.04
	22.57	-1.50	17.20	75.42	36.17	35.26
	39.53	-2.62	30.14	132.15	63.39	61.78
Key metrics
	40.14	12.92	32.61	104.43	59.74	56.64
	11.02%	3.90%	9.40%	28.80%	17.50%	18.10%
	6.19%	-0.40%	5.00%	20.80%	10.60%	11.20%
	—	0.80%	6.30%	—	—	—
	11.43%	-3.50%	-4.60%	6.10%	8.90%	—
	258.82%	-108.70%	-77.20%	108.50%	2.60%	—
	—	-7.66	-43.30	—	—	—
	—	5.11	-1.65	—	—	—
	—	0.07	0.03	—	—	—
	—	28.18	9.63	—	—	—
	—	65.3	56.8	—	—	—
Balance sheet
	—	519.13	511.42	—	—	—
	—	374.40	354.05	—	—	—
	—	0.30	0.42	—	—	—
	—	33.92	27.37	—	—	—
	—	58.27	63.90	—	—	—
	—	15.85	8.45	—	—	—
	—	99.07	97.71	—	—	—
	—	32.52	37.56	—	—	—
	—	115.43	104.18	—	—	—
	—	28.48	10.05	—	—	—
	—	28.48	10.05	—	—	—
	—	0.00	0.00	—	—	—
	—	391.54	392.48	—	—	—
Cash flow
	—	-7.66	-28.44	—	—	—
	—	-4.40	23.30	—	—	—
	—	11.92	0.11	—	—	—
	—	0.00	14.86	—	—	—

Compounded growth

Sales CAGR 3Y: -0.78%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +11.43%
Profit YoY (TTM): +258.82%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 62.25%

Quarter	September 2026	June 2026
Promoter %	62.25%	62.25%

Holder	Type	Holding	Previous	Change
KOTHARI INVESTMENT AND INDUSTRIES PRIVATE LIMITED	Promoter	41.36%	41.36%	0.00%
ANAND VARDHAN KOTHARI	Promoter	9.93%	9.93%	0.00%
M D KOTHARI AND COMPANY LIMITED	Promoter	6.92%	6.92%	0.00%
KOTHARI PHYTOCHEMICALS & INDUSTRIES LIMITED	Promoter	1.74%	1.74%	0.00%
ARUN KUMAR KOTHARI	Promoter	1.70%	1.70%	0.00%
GENERAL INSURANCE CORPORATION OF INDIA	Public	1.61%	1.61%	0.00%
VIKABH SECURITIES PVT. LTD.	Public	1.00%	1.00%	0.00%
PRABHAWATI DEVI KOTHARI	Promoter	0.31%	0.31%	0.00%
PARAMSUKHDAS SUGANCHAND HUF (KARTA - ARUN KUMAR KOTHARI)	Promoter	0.26%	0.26%	0.00%
VEDIKA KOTHARI	Promoter	0.03%	0.03%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Albert David Ltd. S	434	761.00	19.25	0.80%	+11.43% TTM	+258.82% TTM	-12.82%

Filings & corporate actions

Recent announcements

Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting under ....29 Oct 2026 · Board Meeting / Board Meeting
Submission of Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20186 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window from Thursday, 1st October, 2026 for declaration of Unaudited Financial Results for the period ended 30th September, 202622 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication regarding 3rd and 4th reminder for special window for re-lodgement of transfer requests of physical shares11 Sep 2026 · Company Update / Newspaper Publication
Minutes of the 87th Annual General Meeting29 Aug 2026 · AGM/EGM / AGM
Voting Results for the 87th Annual General Meeting of the Company7 Aug 2026 · AGM/EGM / AGM
Scrutinizer''s Report for 87th Annual General Meeting7 Aug 2026 · AGM/EGM / AGM
Newspaper Publication regarding extract of unaudited financial results for the first quarter ended 30th June, 20267 Aug 2026 · Company Update / Newspaper Publication
Proceedings of 87th Annual General Meeting6 Aug 2026 · AGM/EGM / AGM
Intimation under Regulation 30 - Resignation of Senior Managerial Personnel6 Aug 2026 · Company Update / Change in Management
Outcome of Board Meeting dated 06.08.2026 regarding approval of Unaudited Financial Results for quarter ended 30th June, 20266 Aug 2026 · Board Meeting / Outcome of Board Meeting
Newspaper Publication regarding 2nd reminder for Special window for re-lodgement of transfer requests of physical shares28 Jul 2026 · Company Update / Newspaper Publication
Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve To consider, approve and take ....24 Jul 2026 · Board Meeting / Board Meeting
Pursuant to Regulations 36(1)(b) of SEBI Listing Regulations, 2015, the Company has completed the dispatch of the letters containing the web-link of the Annual Report to those members whose ....15 Jul 2026 · Company Update / General
Newspaper Publication dated 14.07.2026 regarding 87th AGM Notice dispatch along with Annual Report F.Y. 2025-26 to shareholders electronically and also via web-link letter to shareholders ....14 Jul 2026 · Company Update / Newspaper Publication
Notice of 87th AGM along with Annual Report for F,Y 2025-2613 Jul 2026 · Others / Reg. 34 (1) Annual Report
87th AGM has been scheduled on 6th August, 2026 at 9:30 A.M.13 Jul 2026 · AGM/EGM / AGM
Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 20184 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Resignation of Senior Managerial Personnel4 Jul 2026 · Company Update / Change in Management
Enclosed herewith copy of Newspaper Publication regarding Notice issued for attention of the shareholders in respect of information regarding 87th Annual General Meeting scheduled to be ....2 Jul 2026 · Company Update / Newspaper Publication
Credit Rating from CARE EDGE Ratings as on 26.06.2026.26 Jun 2026 · Company Update / Credit Rating
Closure of Trading Window from Wednesday 1st July, 2026 for declaration of Unaudited Financial statement for quarter ended 30th June 202623 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Appointment of Mr. Amit Mahla as Additional Director and Whole-time Director & CEO w.e.f 19th June 202619 Jun 2026 · Company Update / Change in Management
Appointment of Mr. Amit Mahla as an Additional Director and Whole-time Director & CEO of the Company and fixed his remuneration. Revised Notice of 87th AGM.19 Jun 2026 · Others / Outcome without intimation
Disclosure pursuant to Reg. 30 - Publication of Notice in Newspapers for transfer of equity shares of the Company to the Investor Education and Protection Fund18 Jun 2026 · Company Update / Newspaper Publication
Resignation of Senior Managerial Personnel30 May 2026 · Company Update / Change in Management
Annual Secretarial Compliance Report for the Financial Year ended March 31, 202627 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Integrated Filing Financials for the fourth quarter and year ended 31st March 202613 May 2026 · Company Update / General
Newspaper publication of Extract of Audited Financial Result for the fourth quarter and year ended 31st March, 202613 May 2026 · Company Update / Newspaper Publication
Regulation 30(5) of SEBI ( LODR), 2015 KMP''S authorised to determine materiality under Regulation 30(5) of SEBI (LODR), 201512 May 2026 · Company Update / General
Book closure date12 May 2026 · Company Update / General
Record date fixed on 30th July 2026 for the purpose of final dividend and determining members eligible to vote for 87th AGM.12 May 2026 · Company Update / General
Board approves final dividend at Rs. 5.00 for the F.Y. 2025-2612 May 2026 · Corp. Action / Dividend
Re-appointment of Cost Auditors for the F.Y. 2026-2712 May 2026 · Company Update / General
Re-appointment of Internal Auditors for the F.Y. 2026-2712 May 2026 · Company Update / General
Change in Management12 May 2026 · Company Update / Change in Management
Financial Results for the Fourth quarter and year ended 31st March, 202612 May 2026 · Result / Financial Results
Outcome of Board Meeting dated 12th May, 2026 to consider and approve Intimation of Board Meeting to consider and approve the Audited Financial Results of the Company for the fourth quarter ....12 May 2026 · Board Meeting / Outcome of Board Meeting
Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....4 May 2026 · Board Meeting / Board Meeting
Submission of Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 20187 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 5.0000	30 Jul 2026	30 Jul 2026	—
Final Dividend - Rs. - 5.0000	25 Jul 2025	25 Jul 2025	—
Final Dividend - Rs. - 11.5000	2 Aug 2024	2 Aug 2024	—

Board meetings

12 Nov 2026 Board Meeting - Financial Results
6 Aug 2026 Board Meeting - Financial Results